tiprankstipranks
Trending News
More News >

Christian Schade Insider Profile

4 Followers
Christian Schade, Director at Integra Lifesciences, holds 63.50K shares in Integra Lifesciences (Ticker: IART), holds 270.25K shares in Aprea Therapeutics (Ticker: APRE), holds ― shares in Omega Therapeutics (Ticker: OMGAQ).
tipranks
Christian Schade

Christian Schade
Integra Lifesciences (IART)
Director

Ranked #74,367 out of 100,956 Corporate Insiders

Profitable Transactions

33%
2 out of 6 Profitable Transactions

Average Return

-13.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5M
59.54%
28.27%
12.19%
0.00%
A breakdown of Christian Schade's holdings

Insider Roles

NRG Energy
(NRG)
Exec VP & Chief Financial Ofc
Integra Lifesciences
(IART)
Director
Aprea Therapeutics
(APRE)
Director
Omega Therapeutics
(OMGAQ)
Director
Roles that Christian Schade holds in companies

Most Profitable Insider Trade

Stock:
Aprea Therapeutics
(APRE)
Rating:Informative Buy
Date:Oct 07, 2019 - Oct 07, 2020
Return:+45.10%
The most profitable trade made by Christian Schade

Christian Schade's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Integra Lifesciences
May 13, 2024
Director
Uninformative Buy
$1.46M
Aprea Therapeutics
Aug 01, 2022
Director
Uninformative Buy
$629.67K
Omega Therapeutics
Director
NRG Energy
Mar 30, 2011
Exec VP & Chief Financial Ofc
Uninformative Sell
105.49K
$3.08M
OMTH
Omthera
List of latest transactions for each holding click on a transaction to see Christian Schade's performance on stock

Christian Schade insider profile FAQ

What is the percentage of profitable transactions made by Christian Schade?
The percentage of profitable transactions made by Christian Schade is 33%.
    What is the average return per transaction made by Christian Schade?
    The average return per transaction made by Christian Schade is -13.40%.
      What stocks does Christian Schade hold?
      Christian Schade holds: IART, APRE, OMGAQ, NRG, OMTH stocks.
        What was Christian Schade’s latest transaction?
        Christian Schade latest transaction was an Uninformative Buy of ―.
          What was Christian Schade's most profitable transaction?
          Christian Schade’s most profitable transaction was an Informative Buy of APRE stock on October 7, 2019. The return on the trade was 45.10%.
            What is Christian Schade's role in Integra Lifesciences?
            Christian Schade's role in Integra Lifesciences is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.